Guangdong Lifestrong Pharmacy Co. Ltd. (301111) — Working Capital to Net Assets Ratio
Guangdong Lifestrong Pharmacy Co. Ltd. (301111) has a Working Capital to Net Assets ratio of 54.1% as of September 2025. Working capital of CN¥407.23 Million (current assets of CN¥534.99 Million minus current liabilities of CN¥127.76 Million) is measured against net assets of CN¥752.66 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. See how leveraged is Guangdong Lifestrong Pharmacy Co. Ltd.'s balance sheet to measure how much of total assets are equity-financed.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Guangdong Lifestrong Pharmacy Co. Ltd. Working Capital to Net Assets (2017–2024)
This chart shows how Guangdong Lifestrong Pharmacy Co. Ltd.'s Working Capital to Net Assets ratio has evolved across 8 annual periods from 2017 to 2024. As of September 2025, the ratio stands at 54.1%, reflecting working capital of CN¥407.23 Million against net assets of CN¥752.66 Million CNY. Check Guangdong Lifestrong Pharmacy Co. Ltd. tangible net worth ratio to evaluate the tangible quality of the company's equity base.
Annual Working Capital to Net Assets for Guangdong Lifestrong Pharmacy Co. Ltd. (2017–2024)
The table below presents the year-by-year Working Capital to Net Assets ratio for Guangdong Lifestrong Pharmacy Co. Ltd. from 2017 to 2024, covering 8 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For live market cap and the full company profile, see 301111 stock market capitalisation.
| Year | WC/NA Ratio | Working Capital (CNY) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2024 | 54.8% | CN¥420.34 Million | CN¥766.75 Million | CN¥515.20 Million | CN¥94.85 Million | ▼ -2.2 pp |
| 2023 | 57.0% | CN¥443.69 Million | CN¥778.21 Million | CN¥509.66 Million | CN¥65.97 Million | ▼ -9.9 pp |
| 2022 | 66.9% | CN¥507.59 Million | CN¥758.67 Million | CN¥600.95 Million | CN¥93.36 Million | ▼ -18.7 pp |
| 2021 | 85.6% | CN¥642.77 Million | CN¥750.85 Million | CN¥708.84 Million | CN¥66.08 Million | ▲ +13.0 pp |
| 2020 | 72.7% | CN¥234.96 Million | CN¥323.41 Million | CN¥283.04 Million | CN¥48.08 Million | ▼ -2.9 pp |
| 2019 | 75.6% | CN¥205.35 Million | CN¥271.68 Million | CN¥251.32 Million | CN¥45.98 Million | ▲ +5.3 pp |
| 2018 | 70.3% | CN¥161.71 Million | CN¥229.97 Million | CN¥227.06 Million | CN¥65.35 Million | ▲ +13.3 pp |
| 2017 | 57.1% | CN¥94.93 Million | CN¥166.37 Million | CN¥209.14 Million | CN¥114.21 Million | — |